Brain RVD-haemopressin, a haemoglobin-derived peptide, inhibits bombesin-induced central activation of adrenomedullary outflow in the rat

British Journal of Pharmacology

Volumn 171, Issue 1, 2014, Pages 202-213

  Tanaka, Kenjiro ^a   Shimizu, Takahiro ^a   Yanagita, Toshihiko ^b   Nemoto, Takayuki ^b   Nakamura, Kumiko ^a   Taniuchi, Keisuke ^a   Dimitriadis, Fotios ^c   Yokotani, Kunihiko ^a   Saito, Motoaki ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

bombesin; brain; cannabinoid CB1 receptor; central adrenomedullary outflow; haemoglobin derived peptides

Indexed keywords

BOMBESIN; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CATECHOLAMINE; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN DERIVATIVE; HEMOPRESSIN; NICOTINE; RVD HEMOPRESSIN; UNCLASSIFIED DRUG;

ADRENAL MEDULLA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE RELEASE; CENTRAL ADRENOMEDULLARY OUTFLOW; CHROMAFFIN CELL; CONTROLLED STUDY; DRUG MECHANISM; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MALE; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

BOMBESIN; BRAIN; CANNABINOID CB1 RECEPTOR; CENTRAL ADRENOMEDULLARY OUTFLOW; HAEMOGLOBIN-DERIVED PEPTIDES;

ADRENAL MEDULLA; ANIMALS; BOMBESIN; CANNABINOID RECEPTOR AGONISTS; CATTLE; CELLS, CULTURED; CHROMAFFIN CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INVERSE AGONISM; EPINEPHRINE; HEMOGLOBINS; INJECTIONS, INTRAVENTRICULAR; MALE; NOREPINEPHRINE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; SPINAL NERVES; TIME FACTORS;

EID: 84890275819     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12471     Document Type: Article

References (52)

1. Alexander SPH, et al. (2013). The Concise Guide to PHARMACOLOGY 2013/14: Overview. Br J Pharmacol 170: 1449-1867.
2. Anastasi A, Erspamer V, Bucci M, (1971). Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia 27: 166-167.
3. Anton AH, Sayre DF, (1962). A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 138: 360-375.
4. 1 receptors. J Biol Chem 287: 36944-36967.
5. Biagioli M, Pinto M, Cesselli D, Zaninello M, Lazarevic D, Roncaglia P, et al. (2009). Unexpected expression of α- and β-globin in mesencephalic dopaminergic neurons and glial cells. Proc Natl Acad Sci U S A 106: 15454-15459.
6. Bisogno T, MacCarrone M, De Petrocellis L, Jarrahian A, Finazzi-Agrò A, Hillard C, et al. (2001). The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. Eur J Biochem 268: 1982-1989.
7. Blais PA, Côté J, Morin J, Larouche A, Gendron G, Fortier A, et al. (2005). Hypotensive effects of hemopressin and bradykinin in rabbits, rats and mice. A comparative study. Peptides 26: 1317-1322.
8. Bomar MG, Samuelsson SJ, Kibler P, Kodukula K, Galande AK, (2012). Hemopressin forms self-assembled fibrillar nanostructures under physiologically relevant conditions. Biomacromolecules 13: 579-583.
9. 1 cannabinoid receptors to reduce food intake in rats and mice. J Neurosci 30: 7369-7376.
10. Dodd GT, Worth AA, Hodkinson DJ, Srivastava RK, Lutz B, Williams SR, et al. (2013). Central functional response to the novel peptide cannabinoid, hemopressin. Neuropharmacology 71: 27-36.
11. fat/fat mice. J Neurochem 113: 871-880.
12. Gelman JS, Dasgupta S, Berezniuk I, Fricker LD, (2013). Analysis of peptides secreted from cultured mouse brain tissue. Biochim Biophys Acta 1834: 2408-2417.
13. Giuffrida A, Beltramo M, Piomelli D, (2001). Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. J Pharmacol Exp Ther 298: 7-14.
14. Gomes I, Grushko JS, Golebiewska U, Hoogendoorn S, Gupta A, Heimann AS, et al. (2009). Novel endogenous peptide agonists of cannabinoid receptors. FASEB J 23: 3020-3029.
15. Gomes I, Dale CS, Casten K, Geigner MA, Gozzo FC, Ferro ES, et al. (2010). Hemoglobin-derived peptides as novel type of bioactive signaling molecules. AAPS J 12: 658-669.
16. 1 receptor. Proc Natl Acad Sci USA 98: 3662-3665.
17. He Y, Hua Y, Liu W, Hu H, Keep RF, Xi G, (2009). Effects of cerebral ischemia on neuronal hemoglobin. J Cereb Blood Flow Metab 29: 596-605.
18. 1 cannabinoid receptors. Proc Natl Acad Sci U S A 104: 20588-20593.
19. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, et al. (2002). International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54: 161-202.
20. Jansen AS, Nguyen XV, Karpitskiy V, Mettenleiter TC, Loewy AD, (1995). Central command neurons of the sympathetic nervous system: basis of the fight-or-flight response. Science 270: 644-646.
21. Jensen RT, Battey JF, Spindel ER, Benya RV, (2008). International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev 60: 1-42.
22. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: Reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
23. Lan R, Liu Q, Fan P, Lin S, Fernando SR, McCallion D, et al. (1999). Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J Med Chem 42: 769-776.
24. Liu L, Zeng M, Stamler JS, (1999). Hemoglobin induction in mouse macrophages. Proc Natl Acad Sci U S A 96: 6643-6647.
25. Luchicchi A, Pistis M, (2012). Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. Mol Neurobiol 46: 374-392.
26. Marcus F, (1985). Preferential cleavage at aspartyl-prolyl peptide bonds in dilute acid. Int J Pept Protein Res 25: 542-546.
27. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
28. Newton DA, Rao KM, Dluhy RA, Baatz JE, (2006). Hemoglobin is expressed by alveolar epithelial cells. J Biol Chem 281: 5668-5676.
29. Okuma Y, Yokotani K, Osumi Y, (1995). Centrally applied bombesin increases nerve activity of both sympathetic and adrenal branch of the splanchnic nerves. Jpn J Pharmacol 68: 227-230.
30. Paxinos G, Watson C, (2005)., Paxinos G, Watson C, (ed). The Rat Brain in Stereotaxic Coordinates. Elsevier Academic Press: Burlington.
31. 2. Pharmacol Rev 62: 588-631.
32. Pyner S, (2009). Neurochemistry of the paraventricular nucleus of the hypothalamus: implications for cardiovascular regulation. J Chem Neuroanat 38: 197-208.
33. Pyner S, Coote JH, (1994). Evidence that sympathetic preganglionic neurones are arranged in target-specific columns in the thoracic spinal cord of the rat. J Comp Neurol 342: 15-22.
34. Pyner S, Coote JH, (2000). Identification of branching paraventricular neurons of the hypothalamus that project to the rostroventrolateral medulla and spinal cord. Neuroscience 100: 549-556.
35. Richter F, Meurers BH, Zhu C, Medvedeva VP, Chesselet MF, (2009). Neurons express hemoglobin α- and β-chains in rat and human brains. J Comp Neurol 515: 538-547.
36. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, et al. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350: 240-244.
37. Rioli V, Gozzo FC, Heimann AS, Linardi A, Krieger JE, Shida CS, et al. (2003). Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme. J Biol Chem 278: 8547-8555.
38. Sawchenko PE, Swanson LW, (1982). Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. J Comp Neurol 205: 260-272.
39. Setton-Avruj CP, Musolino PL, Salis C, Alló M, Bizzozero O, Villar MJ, et al. (2007). Presence of α-globin mRNA and migration of bone marrow cells after sciatic nerve injury suggests their participation in the degeneration/regeneration process. Exp Neurol 203: 568-578.
40. Shimizu T, Okada S, Yamaguchi-Shima N, Yokotani K, (2004). Brain phospholipase C-diacylglycerol lipase pathway is involved in vasopressin-induced release of noradrenaline and adrenaline from adrenal medulla in rats. Eur J Pharmacol 499: 99-105.
41. Shimizu T, Lu L, Yokotani K, (2011). Endogenously generated 2-arachidonoylglycerol plays an inhibitory role in bombesin-induced activation of central adrenomedullary outflow in rats. Eur J Pharmacol 658: 123-131.
42. Shimizu T, Tanaka K, Yokotani K, (2013). Stimulatory and inhibitory roles of brain 2-arachidonoylglycerol in bombesin-induced central activation of adrenomedullary outflow in rats. J Pharmacol Sci 121: 157-171.
43. Swanson LW, Sawchenko PE, (1980). Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology 31: 410-417.
44. Tanaka K, Osako Y, Yuri K, (2010). Juvenile social experience regulates central neuropeptides relevant to emotional and social behaviors. Neuroscience 166: 1036-1042.
45. Tanaka K, Shimizu T, Lu L, Nakamura K, Yokotani K, (2012). Centrally administered bombesin activates COX-containing spinally projecting neurons of the PVN in anesthetized rats. Auton Neurosci 169: 63-69.
46. Viñuela MC, Larsen PJ, (2001). Identification of NPY-induced c-Fos expression in hypothalamic neurones projecting to the dorsal vagal complex and the lower thoracic spinal cord. J Comp Neurol 438: 286-299.
47. Wride MA, Mansergh FC, Adams S, Everitt R, Minnema SE, Rancourt DE, et al. (2003). Expression profiling and gene discovery in the mouse lens. Mol Vis 9: 360-396.
48. Yanagita T, Maruta T, Uezono Y, Satoh S, Yoshikawa N, Nemoto T, et al. (2007). Lithium inhibits function of voltage-dependent sodium channels and catecholamine secretion independent of glycogen synthase kinase-3 in adrenal chromaffin cells. Neuropharmacology 53: 881-889.
49. 2+ influx and catecholamine secretion after lithium withdrawal. Neuropharmacology 57: 311-321.
50. 2+ influx and catecholamine secretion. Neuropharmacology 61: 1265-1274.
51. 3 receptors. Br J Pharmacol 115: 672-676.
52. 3 receptor-mediated sympathetic noradrenaline release in rats. Eur J Pharmacol 512: 29-35.